Laurus Labs Limited — Updates, 24-04-2025: Press Release

Laurus Labs has reported strong Q4 and FY25 financial results, highlighting a positive trajectory in its operations. For Q4 FY25, revenues increased by 19% to ₹1,720 Cr, with EBITDA soaring 84% to ₹477 Cr, reflecting an EBITDA margin of 27.7%. Full-year revenues reached ₹5,554 Cr, a 10% growth, with EBITDA at ₹1,115 Cr (20.1% margin), driven by robust demand for its CDMO services and expanding FDF sales.

The company is focusing on significant growth initiatives, including increased capacity at its facilities and investments in new projects. Laurus is well positioned in the market, emphasizing its diverse offerings and commitment to operational excellence. The company's ongoing collaborations and strong client relationships are expected to provide avenues for further growth.

Investors should note the potential for continued robust performance in FY26, driven by strong fundamentals and strategic expansions, indicating a positive outlook for Laurus Labs. The company has also declared a second interim dividend of ₹0.8 per share in Q4 FY25.